Evaluation of pediatric hydroxyurea prescriptions for patients with sickle cell disease
Hydroxyurea (HU) was one of the main advances in the treatment of sickle cell disease. The use of the drug in children in Brazil is still off-label and is only available in solid pharmaceutical form. The objective of the present study is to evaluate the strategies for adapting the solid dosage form...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Centro Universitário São Camilo
2022-11-01
|
| Seri Bilgileri: | O Mundo da Saúde |
| Konular: | |
| Online Erişim: | https://revistamundodasaude.emnuvens.com.br/mundodasaude/article/view/1440 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|